Armistice Capital, LLC 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 5,200,000 9.540% | 964,000 (+22.76%) | Filing |
| 2024-02-14 2:35 pm Purchase | 2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 4,236,000 9.630% | 840,000 (+24.73%) | Filing |
| 2023-02-14 1:44 pm Purchase | 2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 3,396,000 8.800% | 3,396,000 (New Position) | Filing |
| 2022-02-14 9:54 pm Sale | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 0 0.000% | -3,392,000 (Position Closed) | Filing |
| 2021-02-16 5:11 pm Purchase | 2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 3,392,000 9.100% | 1,392,000 (+69.60%) | Filing |
| 2020-03-05 5:24 pm Purchase | 2020-02-24 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 2,000,000 5.400% | 376,000 (+23.15%) | Filing |
| 2020-02-14 11:28 am Sale | 2019-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 1,624,000 4.400% | -1,212,000 (-42.74%) | Filing |